Document is current

Any future updates will be listed below

Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12890-025-03479-2

Published Online: 2025-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark